Search research articles
Contact Us
Filters
Showing results (41-50 of 189) with videos related to
Page
of 19
Sort By:
Antimicrobial Agents and Chemotherapy
|
January 27, 2004
PBP 2a mutations producing very-high-level resistance to beta-lactams
Yuki Katayama, Hong-Zhong Zhang, Henry F Chambers
The New England Journal of Medicine
|
December 28, 2017
A Trial of Antibiotics for Smaller Skin Abscesses
Robert S Daum, Neha Kumar, Henry F Chambers
Infection and Immunity
|
March 24, 2005
Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets
Ian R Siboo, Henry F Chambers, Paul M Sullam
The New England Journal of Medicine
|
October 22, 2015
The 21st Century Cures Act
Stephen B Calderwood, Barbara E Murray, Henry F Chambers
The New England Journal of Medicine
|
June 18, 2015
Antibacterial Treatment for Uncomplicated Skin Infections
Loren G Miller, Robert S Daum, Henry F Chambers
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis
Matthew R Moore, Françoise Perdreau-Remington, Henry F Chambers
Journal of Bacteriology
|
September 2, 2003
Jumping the barrier to beta-lactam resistance in Staphylococcus aureus
Yuki Katayama, Hong-Zhong Zhang, Dong Hong, et al.
Antimicrobial Agents and Chemotherapy
|
October 24, 2019
Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?
Andre C Kalil, Marisa Holubar, Stan Deresinski, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 2010
A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes
Ritu Banerjee, Michael Gretes, Christopher Harlem, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2024
The Positioning of Ceftobiprole in the Treatment of Staphylococcus aureus Bacteremia
Daniel J Minter, Ayesha Appa, Henry F Chambers, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 189) with videos related to
Sort By:
Page
of 19
Antimicrobial Agents and Chemotherapy
|
January 27, 2004
PBP 2a mutations producing very-high-level resistance to beta-lactams
Yuki Katayama, Hong-Zhong Zhang, Henry F Chambers
The New England Journal of Medicine
|
December 28, 2017
A Trial of Antibiotics for Smaller Skin Abscesses
Robert S Daum, Neha Kumar, Henry F Chambers
Infection and Immunity
|
March 24, 2005
Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets
Ian R Siboo, Henry F Chambers, Paul M Sullam
The New England Journal of Medicine
|
October 22, 2015
The 21st Century Cures Act
Stephen B Calderwood, Barbara E Murray, Henry F Chambers
The New England Journal of Medicine
|
June 18, 2015
Antibacterial Treatment for Uncomplicated Skin Infections
Loren G Miller, Robert S Daum, Henry F Chambers
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis
Matthew R Moore, Françoise Perdreau-Remington, Henry F Chambers
Journal of Bacteriology
|
September 2, 2003
Jumping the barrier to beta-lactam resistance in Staphylococcus aureus
Yuki Katayama, Hong-Zhong Zhang, Dong Hong, et al.
Antimicrobial Agents and Chemotherapy
|
October 24, 2019
Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?
Andre C Kalil, Marisa Holubar, Stan Deresinski, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 2010
A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes
Ritu Banerjee, Michael Gretes, Christopher Harlem, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2024
The Positioning of Ceftobiprole in the Treatment of Staphylococcus aureus Bacteremia
Daniel J Minter, Ayesha Appa, Henry F Chambers, et al.
Page
of 19